I
107TH CONGRESS
1ST SESSION
H. R. 1167
To amend the Public Health Service Act with respect to making progress
toward the goal of eliminating tuberculosis, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MARCH 22, 2001
Mr. BROWN of Ohio (for himself, Mrs. MORELLA, Mr. WAXMAN, Mr. GANSKE,
Mr. ANDREWS, Ms. MCKINNEY, Mr. BACA, Mr. MORAN of Virginia, Mr.
RODRIGUEZ, Mrs. TAUSCHER, Mr. OLVER, Mr. KILDEE, Mrs. CAPPS,
Mrs. WILSON, Mr. CARSON of Oklahoma, Mr. CAPUANO, Mr. GREEN of
Texas, Ms. BROWN of Florida, Ms. LOFGREN, Mr. SANDLIN, Mr. RAN-
GEL, Ms. MCCARTHY of Missouri, Mr. FROST, and Mr. REYES) intro-
duced the following bill; which was referred to the Committee on Energy
and Commerce
A BILL
To amend the Public Health Service Act with respect to
making progress toward the goal of eliminating tuber-
culosis, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Comprehensive Tuber-
culosis Elimination Act of 2001’’.
TITLE I—INTERAGENCY
COLLABORATION
SEC. 101. COMMITTEE ON INTERAGENCY COLLABORATION
FOR TUBERCULOSIS ELIMINATION.
(a) IN GENERAL.—The Secretary of Health and
Human Services shall provide for the ongoing operation
of a committee to be known as the Committee on Inter-
agency Collaboration for Tuberculosis Elimination.
(b) DUTIES.—
(1) IN GENERAL.—For the purpose of making
progress toward the goal of eliminating tuberculosis,
the Committee shall provide to the Secretary and
other appropriate Federal officials advice on coordi-
nating the activities of the Public Health Service
and other Federal agencies that relate to such dis-
ease and on efficiently utilizing the Federal re-
sources involved. In carrying out this subsection, the
Committee shall consider the recommendations of
the Institute of Medicine regarding the elimination
of tuberculosis.
(2) NATIONAL
PLAN.—In carrying out para-
graph (1), the Committee, in consultation with ap-
propriate public and private entities, shall make rec-
ommendations on the development and implementa-
tion of a national plan that, with respect to tuber-
culosis, provides for training and education for
health care workers, persons with or at-risk of such
disease, and the general public.
(3) GLOBAL ACTIVITIES.—In carrying out para-
graph (1), the Committee, in consultation with ap-
propriate public and private entities, shall make rec-
ommendations for the development and implementa-
tion of a plan to guide the involvement of the United
States in global tuberculosis-control activities, in-
cluding recommendations regarding policies, strate-
gies, objectives, and priorities. Such recommenda-
tions for the plan shall have a focus on high-burden
countries and on access to directly observed treat-
ment, short course (commonly known as DOTS).
(c) COMPOSITION.—The Committee shall be com-
posed of—
(1) representatives from the Centers for Dis-
ease Control and Prevention, the National Institutes
of Health, the Agency for Healthcare Research and
Quality, and all other Federal departments and
agencies that carry out activities relating to tuber-
culosis; and
(2) members appointed from among individuals
who are not officers or employees of the Federal
Government.
(d) DEFINITIONS.—For purposes of this section:
(1) The term ‘‘Committee’’ means the Com-
mittee on Interagency Collaboration for Tuberculosis
Elimination.
(2) The term ‘‘Secretary’’ means the Secretary
of Health and Human Services.
TITLE 
II—CENTERS 
FOR 
DIS-
EASE CONTROL AND PREVEN-
TION
SEC. 201. NATIONAL PROGRAM FOR TUBERCULOSIS ELIMI-
NATION.
Section 317E of the Public Health Service Act (42
U.S.C. 247b–6) is amended—
(1) by striking the heading for the section and
inserting the following:
‘‘NATIONAL PROGRAM FOR TUBERCULOSIS
ELIMINATION’’;
(2) by amending subsection (b) to read as fol-
lows:
‘‘(b) RESEARCH, DEMONSTRATION PROJECTS, EDU-
CATION, AND TRAINING.—With respect to the prevention,
control, and elimination of tuberculosis, the Secretary
may, directly or through grants to public or nonprofit pri-
vate entities, carry out the following:
‘‘(1) Research, with priority given to research
concerning—
‘‘(A) diagnosis and treatment of latent in-
fection of tuberculosis;
‘‘(B) strains of tuberculosis resistant to
drugs;
‘‘(C) cases of tuberculosis that affect cer-
tain populations; and
‘‘(D) clinical trials, including a tuberculosis
trials consortium.
‘‘(2) Demonstration projects for—
‘‘(A) the development of regional capabili-
ties for the prevention, control, and elimination
of tuberculosis; and
‘‘(B) collaboration with the Immigration
and Naturalization Service to identify and treat
immigrants with active or latent tuberculosis in-
fection.
‘‘(3) Public information and education pro-
grams.
‘‘(4) Education, training and clinical skills im-
provement activities for health professionals, includ-
ing allied health personnel.
‘‘(5) Support of model centers to carry out ac-
tivities under paragraphs (1) through (4).
‘‘(6) Collaboration with international organiza-
tions and foreign countries in carrying out such ac-
tivities, including coordinating activities through the
Committee on Interagency Collaboration for Tuber-
culosis Elimination.’’;
(3) in subsection (f), by adding at the end the
following:
‘‘(4) ANNUAL REPORTS.—The Council shall an-
nually submit to the Congress and the Secretary a
report on the activities carried out under this sub-
section. The report shall include the opinion of the
Council on the extent to which the recommendations
of the Institute of Medicine regarding tuberculosis
have been implemented.’’; and
(4) by amending subsection (g) to read as fol-
lows:
‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
to be appropriated $528,000,000 for fiscal year 2002, and
such sums as may be necessary for each of the fiscal years
2003 through 2006.’’.
TITLE III—NATIONAL
INSTITUTES OF HEALTH
SEC. 301. ACTIVITIES OF NATIONAL HEART, LUNG, AND
BLOOD INSTITUTE.
Subpart 2 of part C of title IV of the Public Health
Service Act (42 U.S.C. 285b et seq.) is amended by insert-
ing after section 424B the following section:
‘‘TUBERCULOSIS
‘‘SEC. 424C. (a) IN GENERAL.—The Director of the
Institute shall expand, intensify, and coordinate research
and related activities of the Institute with respect to tuber-
culosis, including activities toward the goal of eliminating
such disease.
‘‘(b) CERTAIN ACTIVITIES.—Activities under sub-
section (a) shall include—
‘‘(1) enhancing basic and clinical research on
tuberculosis; and
‘‘(2) expanding research on the relationship be-
tween such disease and the human immunodeficiency
virus.
‘‘(c) RESEARCH EDUCATION.—
‘‘(1) TUBERCULOSIS ACADEMIC AWARDS.—The
Director of the Institute may provide awards to fac-
ulty of schools of medicine or osteopathic medicine
to assist such faculty in developing high quality cur-